Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19

BACKGROUND: Despite its clinical significance, the risk of severe infection requiring hospitalization among outpatients with severe acute respiratory syndrome coronavirus 2 infection who receive angiotensin‐converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) remains uncertain...

Descripción completa

Detalles Bibliográficos
Autores principales: Khera, Rohan, Clark, Callahan, Lu, Yuan, Guo, Yinglong, Ren, Sheng, Truax, Brandon, Spatz, Erica S., Murugiah, Karthik, Lin, Zhenqiu, Omer, Saad B., Vojta, Deneen, Krumholz, Harlan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403305/
https://www.ncbi.nlm.nih.gov/pubmed/33624516
http://dx.doi.org/10.1161/JAHA.120.018086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403305/
https://www.ncbi.nlm.nih.gov/pubmed/33624516
http://dx.doi.org/10.1161/JAHA.120.018086

Ejemplares similares